Systematic Review of Recommendations on the Use of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Cancer: Comment on the Article by Lopez‐Olivo et al

Antirheumatic Drugs ◽

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis

BMJ ◽

10.1136/bmj.i1777 ◽

2016 ◽

pp. i1777 ◽

Cited By ~ 80

Author(s):

Glen S Hazlewood ◽

Cheryl Barnabe ◽

George Tomlinson ◽

Deborah Marshall ◽

Dan Devoe ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Combination Therapy ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Cochrane Systematic Review ◽

Chinese herbal medicines versus disease modifying antirheumatic drugs for management of rheumatoid arthritis: A systematic review

European Journal of Integrative Medicine ◽

10.1016/j.eujim.2011.06.003 ◽

2011 ◽

Vol 3 (3) ◽

pp. e219-e231 ◽

Cited By ~ 8

Author(s):

Chi Zhang ◽

Miao Jiang ◽

Aiping Lu

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Herbal Medicines ◽

Antirheumatic Drugs ◽

Chinese Herbal Medicines ◽

Chinese Herbal ◽

Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

Arthritis Care & Research ◽

10.1002/acr.23875 ◽

2020 ◽

Vol 72 (4) ◽

pp. 561-576 ◽

Cited By ~ 19

Author(s):

Siddharth Singh ◽

Mathurin Fumery ◽

Abha G. Singh ◽

Namrata Singh ◽

Larry J. Prokop ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Cardiovascular Events ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Comparative Risk ◽

AB0496 Efficacy of Tofacitinib in Combination with Methotrexate Compared to Biological Disease Modifying Antirheumatic Drugs in Combination with Methotrexate in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate: Overview of Systematic Review

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.6237 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 1064.2-1064

Author(s):

J.M. Reyes Sanchez ◽

A.E. Rodriguez ◽

V. Prieto

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Inadequate Response ◽

Antirheumatic Drugs ◽

THU0196 Systematic review and meta-analysis of malignancies, excluding non-melanoma skin cancer, in patients with rheumatoid arthritis treated with tofacitinib or biologic disease-modifying antirheumatic drugs

10.1136/annrheumdis-2017-eular.1960 ◽

2017 ◽

Author(s):

JJ Gomez-Reino ◽

T Checchio ◽

J Geier ◽

M Boy ◽

S Ahadieh ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Skin Cancer ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Non Melanoma Skin Cancer ◽

Disease Modifying ◽

Melanoma Skin

Corrigendum: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation

Health Technology Assessment ◽

10.3310/hta20350-c201611 ◽

2016 ◽

Vol 20 (35) ◽

pp. 611-614 ◽

Cited By ~ 3

Author(s):

Matt Stevenson ◽

Rachel Archer ◽

Jon Tosh ◽

Emma Simpson ◽

Emma Everson-Hock ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Economic Evaluation ◽

Certolizumab Pegol ◽

Antirheumatic Drugs ◽

Previously Treated ◽

Abstract Correction to Table 209.

PMS5 Comparative Efficacy of Filgotinib Versus Alternative Treatments for Rheumatoid Arthritis in Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: A Systematic Review and Network Meta-Analysis

Value in Health ◽

10.1016/j.jval.2020.08.1136 ◽

2020 ◽

Vol 23 ◽

pp. S592-S593

Author(s):

I. Jacob ◽

L. Beresford ◽

K. Butler ◽

B. McNamara ◽

J. Dennis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Meta Analysis ◽

Inadequate Response ◽

Comparative Efficacy ◽

Alternative Treatments ◽

Antirheumatic Drugs ◽

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.099861 ◽

2008 ◽

Vol 68 (7) ◽

pp. 1105-1112 ◽

Cited By ~ 90

Author(s):

W Katchamart ◽

J Trudeau ◽

V Phumethum ◽

C Bombardier

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Combination Therapy ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review

Arthritis Care & Research ◽

10.1002/acr.20338 ◽

2010 ◽

Vol 63 (1) ◽

pp. 65-78 ◽

Cited By ~ 56

Author(s):

Gabrielle van der Velde ◽

Ba' Pham ◽

Márcio Machado ◽

Luciano Ieraci ◽

William Witteman ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Cost Effectiveness ◽

Antirheumatic Drugs ◽

Biologic Response ◽

Faculty Opinions recommendation of Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726306486.793521882 ◽

2016 ◽

Author(s):

David Scott

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Combination Therapy ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Cochrane Systematic Review ◽